Curvopeptin-3
| Internal ID | fef6d192-27e4-46e4-9877-1a49f7dac1ac |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[2-[24-[[3-[[6-amino-2-[[2-[[24-[[2-[[2-[(2-aminoacetyl)amino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-18-methyl-15,21-dimethylidene-6,9,12-tris(2-methylpropyl)-5,8,11,14,17,20,23-heptaoxo-1-thia-4,7,10,13,16,19,22-heptazacyclopentacosane-3-carbonyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]-2-oxo-4-phenylbutanoyl]amino]-18-benzyl-12-(1-hydroxyethyl)-21-methyl-15-methylidene-6,9-bis(2-methylpropyl)-8,11,14,17,20,23-hexaoxo-1-thia-4,7,10,13,16,19,22-heptazacyclopentacos-3-yl]-2-oxoethyl]-4-methylpentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C109H167N23O29S2/c1-53(2)35-68(109(160)161)44-84(134)80-49-162-51-82(105(156)117-63(18)93(144)123-77(43-67-31-25-22-26-32-67)96(147)115-64(19)94(145)132-88(65(20)133)107(158)128-72(37-55(5)6)97(148)118-69(48-112-80)36-54(3)4)131-108(159)89(140)71(42-66-29-23-21-24-30-66)121-95(146)70(33-27-28-34-110)120-103(154)79(46-87(138)139)127-106(157)83-52-163-50-81(129-100(151)76(41-59(13)14)126-102(153)78(45-86(136)137)119-85(135)47-111)104(155)116-61(16)91(142)113-60(15)90(141)114-62(17)92(143)122-73(38-56(7)8)98(149)124-74(39-57(9)10)99(150)125-75(40-58(11)12)101(152)130-83/h21-26,29-32,53-60,63,65,68-83,88,112,133H,16-17,19,27-28,33-52,110-111H2,1-15,18,20H3,(H,113,142)(H,114,141)(H,115,147)(H,116,155)(H,117,156)(H,118,148)(H,119,135)(H,120,154)(H,121,146)(H,122,143)(H,123,144)(H,124,149)(H,125,150)(H,126,153)(H,127,157)(H,128,158)(H,129,151)(H,130,152)(H,131,159)(H,132,145)(H,136,137)(H,138,139)(H,160,161) |
| InChI Key | HKLNUHNYFDXFFR-UHFFFAOYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C109H167N23O29S2 |
| Molecular Weight | 2327.80 g/mol |
| Exact Mass | 2327.1775036 g/mol |
| Topological Polar Surface Area (TPSA) | 863.00 Ų |
| XlogP | -2.70 |
| RefChem:128937 |
| 2-(2-(24-((3-((6-amino-2-((2-(((24-((2-((2-((2-amino-1-hydroxyethylidene)amino)-3-carboxy-1-hydroxypropylidene)amino)-1-hydroxy-4-methylpentylidene)amino)-5,8,11,14,17,20,23-heptahydroxy-18-methyl-15,21-dimethylidene-6,9,12-tris(2-methylpropyl)-1-thia-4,7,10,13,16,19,22-heptazacyclopentacosa-4,7,10,13,16,19,22-heptaen-3-yl)-hydroxymethylidene)amino)-3-carboxy-1-hydroxypropylidene)amino)-1-hydroxyhexylidene)amino)-2-oxo-4-phenylbutanoyl)amino)-18-benzyl-8,11,14,17,20,23-hexahydroxy-12-(1-hydroxyethyl)-21-methyl-15-methylidene-6,9-bis(2-methylpropyl)-1-thia-4,7,10,13,16,19,22-heptazacyclopentacosa-7,10,13,16,19,22-hexaen-3-yl)-2-oxoethyl)-4-methylpentanoic acid |
| 2-(2-(24-((3-((6-amino-2-((2-((24-((2-((2-((2-aminoacetyl)amino)-3-carboxypropanoyl)amino)-4-methylpentanoyl)amino)-18-methyl-15,21-dimethylidene-6,9,12-tris(2-methylpropyl)-5,8,11,14,17,20,23-heptaoxo-1-thia-4,7,10,13,16,19,22-heptazacyclopentacosane-3-carbonyl)amino)-3-carboxypropanoyl)amino)hexanoyl)amino)-2-oxo-4-phenylbutanoyl)amino)-18-benzyl-12-(1-hydroxyethyl)-21-methyl-15-methylidene-6,9-bis(2-methylpropyl)-8,11,14,17,20,23-hexaoxo-1-thia-4,7,10,13,16,19,22-heptazacyclopentacos-3-yl)-2-oxoethyl)-4-methylpentanoic acid |
| 2-(2-(24-(3-((6-amino-2-((2-(((24-((2-((2-((2-amino-1-hydroxyethylidene)amino)-3-carboxy-1-hydroxypropylidene)amino)-1-hydroxy-4-methylpentylidene)amino)-5,8,11,14,17,20,23-heptahydroxy-18-methyl-15,21-dimethylidene-6,9,12-tris(2-methylpropyl)-1-thia-4,7,10,13,16,19,22-heptaazacyclopentacosa-4,7,10,13,16,19,22-heptaen-3-yl)(hydroxy)methylidene)amino)-3-carboxy-1-hydroxypropylidene)amino)-1-hydroxyhexylidene)amino)-2-oxo-4-phenylbutanamido)-18-benzyl-8,11,14,17,20,23-hexahydroxy-12-(1-hydroxyethyl)-21-methyl-15-methylidene-6,9-bis(2-methylpropyl)-1-thia-4,7,10,13,16,19,22-heptaazacyclopentacosa-7,10,13,16,19,22-hexaen-3-yl)-2-oxoethyl)-4-methylpentanoate |
| 2-(2-{24-[3-({6-amino-2-[(2-{[(24-{[2-({2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene}amino)-1-hydroxy-4-methylpentylidene]amino}-5,8,11,14,17,20,23-heptahydroxy-18-methyl-15,21-dimethylidene-6,9,12-tris(2-methylpropyl)-1-thia-4,7,10,13,16,19,22-heptaazacyclopentacosa-4,7,10,13,16,19,22-heptaen-3-yl)(hydroxy)methylidene]amino}-3-carboxy-1-hydroxypropylidene)amino]-1-hydroxyhexylidene}amino)-2-oxo-4-phenylbutanamido]-18-benzyl-8,11,14,17,20,23-hexahydroxy-12-(1-hydroxyethyl)-21-methyl-15-methylidene-6,9-bis(2-methylpropyl)-1-thia-4,7,10,13,16,19,22-heptaazacyclopentacosa-7,10,13,16,19,22-hexaen-3-yl}-2-oxoethyl)-4-methylpentanoate |
| 2-[2-[24-[[3-[[6-amino-2-[[2-[[[24-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-4-methylpentylidene]amino]-5,8,11,14,17,20,23-heptahydroxy-18-methyl-15,21-dimethylidene-6,9,12-tris(2-methylpropyl)-1-thia-4,7,10,13,16,19,22-heptazacyclopentacosa-4,7,10,13,16,19,22-heptaen-3-yl]-hydroxymethylidene]amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxyhexylidene]amino]-2-oxo-4-phenylbutanoyl]amino]-18-benzyl-8,11,14,17,20,23-hexahydroxy-12-(1-hydroxyethyl)-21-methyl-15-methylidene-6,9-bis(2-methylpropyl)-1-thia-4,7,10,13,16,19,22-heptazacyclopentacosa-7,10,13,16,19,22-hexaen-3-yl]-2-oxoethyl]-4-methylpentanoic acid |
| 2-[2-[24-[[3-[[6-amino-2-[[2-[[24-[[2-[[2-[(2-aminoacetyl)amino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]-18-methyl-15,21-dimethylidene-6,9,12-tris(2-methylpropyl)-5,8,11,14,17,20,23-heptaoxo-1-thia-4,7,10,13,16,19,22-heptazacyclopentacosane-3-carbonyl]amino]-3-carboxypropanoyl]amino]hexanoyl]amino]-2-oxo-4-phenylbutanoyl]amino]-18-benzyl-12-(1-hydroxyethyl)-21-methyl-15-methylidene-6,9-bis(2-methylpropyl)-8,11,14,17,20,23-hexaoxo-1-thia-4,7,10,13,16,19,22-heptazacyclopentacos-3-yl]-2-oxoethyl]-4-methylpentanoic acid |
| CHEBI:214357 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| No predicted properties yet! | |||
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.93% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.90% | 96.61% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 99.18% | 90.17% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 99.11% | 97.23% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 99.08% | 90.20% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.99% | 91.11% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.68% | 96.09% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 98.17% | 97.64% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 98.14% | 93.10% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 98.01% | 88.42% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.24% | 98.33% |
| CHEMBL236 | P41143 | Delta opioid receptor | 96.49% | 99.35% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 96.36% | 97.14% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 96.23% | 95.50% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.10% | 94.45% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 95.93% | 97.09% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 95.87% | 96.47% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 95.81% | 98.05% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 94.00% | 99.17% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 93.86% | 90.93% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 93.79% | 95.56% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 93.71% | 97.21% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 93.36% | 93.56% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 92.71% | 83.82% |
| CHEMBL2327 | P21452 | Neurokinin 2 receptor | 92.39% | 98.89% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 91.20% | 98.24% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 91.09% | 100.00% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 90.92% | 93.00% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 90.53% | 94.66% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 90.47% | 92.29% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 90.36% | 93.03% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 90.20% | 95.89% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 90.11% | 98.10% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 90.08% | 97.33% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 89.75% | 95.00% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 89.44% | 90.71% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 89.06% | 96.90% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 88.89% | 100.00% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 88.04% | 91.71% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 87.58% | 99.15% |
| CHEMBL3468 | P55210 | Caspase-7 | 86.44% | 95.68% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 86.10% | 96.95% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 85.17% | 82.38% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 84.67% | 88.10% |
| CHEMBL222 | P23975 | Norepinephrine transporter | 83.27% | 96.06% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 83.22% | 92.88% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 82.94% | 96.00% |
| CHEMBL2821 | P00748 | Coagulation factor XII | 82.90% | 96.21% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 82.64% | 100.00% |
| CHEMBL4072 | P07858 | Cathepsin B | 82.27% | 93.67% |
| CHEMBL4801 | P29466 | Caspase-1 | 81.75% | 96.85% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 81.65% | 96.11% |
| CHEMBL2553 | Q15418 | Ribosomal protein S6 kinase alpha 1 | 81.36% | 85.11% |
| CHEMBL5028 | O14672 | ADAM10 | 80.33% | 97.50% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 80.33% | 94.55% |
| CHEMBL3776 | Q14790 | Caspase-8 | 80.25% | 97.06% |
| CHEMBL3891 | P07384 | Calpain 1 | 80.03% | 93.04% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 80.02% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 80.01% | 91.19% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139587260 |
| LOTUS | LTS0100032 |
| wikiData | Q77561346 |